| Sample | Title | Value | Rank |
|---|
| GSM303966 | SLE-7 #4 @12wks, asymptomatic (-2077090517) | 7.14041 | 21 |
| GSM303972 | SLE-7 #3 @12wks, asymptomatic (-2077090523) | 7.62367 | 20 |
| GSM303986 | SLE-7 #2 @12wks, asymptomatic (-2077090529) | 9.23027 | 23 |
| GSM303991 | SLE-7 #1 @12wks, asymptomatic (-2077090535) | 10.0776 | 22 |
| GSM303961 | SLE-7 #1 @36wks, asymptomatic on treatment with sirolimus (-2101366109) | 41.3835 | 47 |
| GSM303979 | SLE-7 #3 @36wks, asymptomatic on treatment with sirolimus (-2101365196) | 14.3157 | 22 |
| GSM303985 | SLE-7 #2 @36wks, asymptomatic on treatment with sirolimus (-2101365652) | 12.3003 | 24 |
| GSM303971 | SLE-7 #2 @36wks, diseased/symptomatic (-2101366115) | 19.4262 | 33 |
| GSM303973 | SLE-7 #1 @36wks, diseased/symptomatic (-2101366147) | 30.8182 | 40 |
| GSM303980 | SLE-7 #3 @36wks, diseased/symptomatic (-2102085829) | 19.5952 | 28 |
| GSM303962 | SLE-7 #3 @42wks, asymptomatic on treatment with sirolimus (-2101365164) | 11.2811 | 20 |
| GSM303978 | SLE-7 #2 @42wks, asymptomatic on treatment with sirolimus (-2102085846) | 17.0101 | 27 |
| GSM303982 | SLE-7 #1 @42wks, asymptomatic on treatment with sirolimus (-2101365170) | 30.3885 | 37 |
| GSM303965 | SLE-7 #2 @42wks, diseased/symptomatic (-2102085823) | 14.5592 | 23 |
| GSM303968 | SLE-7 #1 @42wks, diseased/symptomatic (-2101365185) | 24.6581 | 36 |
| GSM303981 | SLE-7 #3 @42wks, diseased/symptomatic (-2101365176) | 29.9807 | 40 |